These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 11710695
21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
22. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E. Lupus; 2007 Dec; 16(12):929-38. PubMed ID: 18042586 [Abstract] [Full Text] [Related]
23. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R. J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [Abstract] [Full Text] [Related]
24. Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome. Laczik R, Szodoray P, Veres K, Lakos G, Sipka S, Szegedi G, Soltész P. Autoimmunity; 2010 Jun; 43(4):334-9. PubMed ID: 20187701 [Abstract] [Full Text] [Related]
25. Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. Amengual O, Atsumi T, Khamashta MA, Tinahones F, Hughes GR. Br J Rheumatol; 1997 Sep; 36(9):964-8. PubMed ID: 9376992 [Abstract] [Full Text] [Related]
26. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
27. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS. Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [Abstract] [Full Text] [Related]
28. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME, Cabiedes J, Reyes E, Cabral AR. Rev Invest Clin; 2005 Sep; 57(4):563-71. PubMed ID: 16315641 [Abstract] [Full Text] [Related]
29. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY. Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827 [Abstract] [Full Text] [Related]
30. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR. Clin Dev Immunol; 2003 Feb; 10(2-4):203-11. PubMed ID: 14768953 [Abstract] [Full Text] [Related]
32. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Radulescu L, Stancu C, Antohe F. Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494 [Abstract] [Full Text] [Related]
33. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus. Koskenmies S, Vaarala O, Widen E, Kere J, Palosuo T, Julkunen H. Scand J Rheumatol; 2004 Jul; 33(4):246-52. PubMed ID: 15370721 [Abstract] [Full Text] [Related]
34. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. Türkoğlu O, Bariş N, Kütükçüler N, Senarslan O, Güneri S, Atilla G. J Periodontol; 2008 Feb; 79(2):332-40. PubMed ID: 18251648 [Abstract] [Full Text] [Related]
35. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Matsuura E, Kobayashi K, Hurley BL, Lopez LR. Lupus; 2006 Feb; 15(7):478-83. PubMed ID: 16898186 [Abstract] [Full Text] [Related]
36. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. Atsumi T, Khamashta MA, Andujar C, Leandro MJ, Amengual O, Ames PR, Hughes GR. J Rheumatol; 1998 Jan; 25(1):69-73. PubMed ID: 9458205 [Abstract] [Full Text] [Related]
37. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus. Lopez LR, Hurley BL, Simpson DF, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948 [Abstract] [Full Text] [Related]
38. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation. Matsuura E, Kobayashi K, Matsunami Y, Lopez LR. Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205 [Abstract] [Full Text] [Related]
39. [Antibodies against low density oxidized lipoproteins in type 2 diabetics]. Malícková K, Skrha J, Janatková I, Vanková Z, Fucíková T. Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272 [Abstract] [Full Text] [Related]